initiate coverage

UOB initiates 'buy' on iFAST with target price of $3.34 - THE EDGE SINGAPORE

Broker's Calls

UOB initiates 'buy' on iFAST with target price of $3.34

iFAST Corporation’s rapid growth of asset and wealth management in Asia have led to UOB's "buy" call on the stock.
Analysts positive on Kimly as it feeds hungry heartlanders - THE EDGE SINGAPORE

Broker's Calls

Analysts positive on Kimly as it feeds hungry heartlanders

With working from home becoming the new norm, Kimly's coffeeshops are seeing more hungry patrons

Broker's Calls

Phillip Securities initiates 'buy' for iX Biopharma on prospect of turning profitable in FY21

The biotech company could finally turn profitable in FY21 as revenue could be bumped up by as much as 250%, says the brokerage.

Broker's Calls

CGS-CIMB starts SBS Transit at 'add' on ridership recovery

As at 2.48pm, shares in SBS Transit were trading 6 cents higher, or 2.2% up, at $2.85.

Broker's Calls

Phillip Securities initiates 'buy' on First Sponsor with TP of $1.65

The brokerage says the property developer has unrecognised property development revenue of $586 million.

Broker's Calls

CGS-CIMB initiates 'buy' on Lendlease Global Commercial REIT, calls it 'an undervalued REIT'

The brokerage's target price for LREIT is at 85.4 cents, which represents a 30.3% upside to its last closed price of 65.5 cents.

Broker's Calls

Food to fuel Koufu's growth

Food to fuel Koufu's growth

Broker's Calls

PhillipCapital starts coverage on UG Healthcare at 'buy' on own branded gloves and distribution network

“With its own branded gloves and distribution network, UG Healthcare should be able to monetize a larger share of supply-chain profits, starting from manufacturing to distribution,” says PhillipCapital's head of research Paul Chew.

Broker's Calls

KGI starts Singapore Medical Group at 'outperform' on diverse network of specialist healthcare services

KGI Securities has initiated coverage on Singapore Medical Group (SMG) with an “outperform” call and target price of 34 cents, which represents a total upside of 39.0%, including a forecasted dividend yield of 1.4% for FY21F.

Broker's Calls

CGS-CIMB initiates coverage on Grand Venture Technology at 'buy' on capability differentiation

CGS-CIMB Research has initiated coverage on Grand Venture Technology (GVT) with an “add” or “buy” call and target price of 26.2 cents.
×